Platform & Pipeline
We are developing a proprietary platform for the treatment of Acute Myeloid Leukemia and other blood cancers
Our Platform
Vor Bio is developing a new treatment platform based upon proven technologies in genome engineering, engineered Hematopoietic Stem Cell (eHSC) biology, and CAR-T cells that could change the standard of care for blood cancers.
Our Pipeline
Our pipeline demonstrates the strength and potential of our novel platform, with two clinical trials currently recruiting patients with relapsed/refractory AML and MDS.
Our Approach